Correlation Between Edgewise Therapeutics and Solid Biosciences
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Solid Biosciences LLC, you can compare the effects of market volatilities on Edgewise Therapeutics and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Solid Biosciences.
Diversification Opportunities for Edgewise Therapeutics and Solid Biosciences
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Edgewise and Solid is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Solid Biosciences go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Solid Biosciences
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.8 times more return on investment than Solid Biosciences. However, Edgewise Therapeutics is 1.25 times less risky than Solid Biosciences. It trades about 0.03 of its potential returns per unit of risk. Solid Biosciences LLC is currently generating about -0.22 per unit of risk. If you would invest 2,772 in Edgewise Therapeutics on November 4, 2024 and sell it today you would earn a total of 30.00 from holding Edgewise Therapeutics or generate 1.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Solid Biosciences LLC
Performance |
| Timeline |
| Edgewise Therapeutics |
| Solid Biosciences LLC |
Edgewise Therapeutics and Solid Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Solid Biosciences
The main advantage of trading using opposite Edgewise Therapeutics and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |